TABLE 4.
INCIDENCE OF QFT REVERSIONS AMONG HEALTH CARE WORKERS WITH EITHER QUANTIFERON-TB GOLD IN-TUBE ASSAY–POSITIVE/TUBERCULIN SKIN TEST–POSITIVE RESULTS, OR QUANTIFERON-TB GOLD IN-TUBE ASSAY–POSITIVE/TUBERCULIN SKIN TEST–NEGATIVE RESULTS AT BASELINE*
Baseline IFN-γ Response, IU/ml | No. Retested after 18 Mo | No. That Received INH after Baseline Survey (%) | Total Reversions | Incidence of Reversions (%) | p Value for Trend in Reversion Rates across IFN-γ Categories |
---|---|---|---|---|---|
0.35–0.69 | 11 | 1 (9) | 6 | 6/11 (55) | < 0.01 |
0.7–1.0 | 2 | 0 (0) | 1 | 1/2 (50) | |
1.1–5.0 | 9 | 3 (33) | 1 | 1/9 (11) | |
> 5.0 | 16 | 9 (56) | 1 | 1/16 (6) | |
Total | 38 | 13 (34) | 9 | 9/38 (24) |
Definition of abbreviations: TST = tuberculin skin test; QFT = QuantiFERON-TB Gold In-Tube assay; INH = isoniazid.
n = 38.